Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease.
source https://nypost.com/2020/11/06/fda-panel-urges-rejection-of-experimental-alzheimers-drug/
0 Comments